Earnings Call · Q3 FY2022·2022-11-07

Q3 22EPS 0.00%·Rev n/aQ2 22EPS +6.85%·Rev n/aQ1 22EPS +31.61%·Rev n/aQ4 21EPS +27.97%·Rev n/a⚠ consensus missing

Fulgent Genetics, Inc. FLGT

Melanie Solomon — Investor Relations

Ming Hsieh — Chief Executive Officer

Dr. Ray Yin — Co-founder

Brandon Perthuis — Head of Sales or similar role

Paul Kim — Chief Financial Officer

−2.3%1d on move date−2.8% vs SPY3d+3.9%5d+1.1%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FLGT calls or request research access.

More FLGT calls Browse calls Request research access